US 10590093
1,2,4-oxadiazole derivatives as immunomodulators
granted A61KA61K31/395A61K31/4245
Quick answer
US patent 10590093 (1,2,4-oxadiazole derivatives as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 53
- CPC classes
- A61K, A61K31/395, A61K31/4245, A61K31/433, A61K45/06